drugset / Trial / NCT01036035

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

NCT01036035

Phase 1 Completed 18 enrolled TheraVida, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

THVD-201 is a novel combination of a muscarinic antagonist (tolterodine) and a muscarinic agonist (pilocarpine).

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pilocarpine Unknown
Comparator THVD-201 Unknown
Comparator Tolterodine Small molecule

Indications

No indication recorded.